Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-01-06

EMA Authorised: Talmanco (previously Tadalafil Generics) (tadalafil) — Viatris Limited

View source ↗

Summary

Talmanco has been authorised in the EU as a generic tadalafil product with indications in hypertension and pulmonary arterial hypertension, with Viatris Limited…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Talmanco (tadalafil)

Snippet

Status: Authorised. Therapeutic area: Hypertension, Pulmonary. MAH: Viatris Limited. Decision date: 06/01/2026